Japanese Phase 1 Study to Evaluate Tolerated Dose, Safety, and Efficacy of Pomalidomide in Patients With Refractory or Relapsed and Refractory Multiple Myeloma
Clinical trial NCT01568294 · COMPLETED
Trial details
- NCT number
- NCT01568294
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2015-07-08
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.